Table 3 Responses to lenalidomide in 5q−... | American Society of Hematology

Table 3

Responses to lenalidomide in 5q− and non-5q− MDS patients

	Non-5q−	5q−
Transfusion independence	26%	67%
Median hemoglobin rise	3.2 g/dL	5.4 g/dL
Median time to response	4.8 weeks	4.6 weeks
Complete cytogenetic response	10%	44%

	Non-5q−	5q−
Transfusion independence	26%	67%
Median hemoglobin rise	3.2 g/dL	5.4 g/dL
Median time to response	4.8 weeks	4.6 weeks
Complete cytogenetic response	10%	44%

Modified from List et al⁴⁵ and Raza et al⁴⁶ with permission.